01.08.2024
Therapeutics
$3,027,800.00
36 months
Standardized Microbiota Transplant Therapy in Crohn's Disease. Pilot Trial.
This project aims to establish the efficacy of microbial transplant therapy in three different subtypes of Crohn's disease and to provide valuable insight into the microbial changes associated with positive clinical outcomes.